|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Matsuoka R, Yoshida MC, Furutani Y,
Imamura S, Kanda N, Yanagisawa M, Masaki T and Takao A: Human
smooth muscle myosin heavy chain gene mapped to chromosomal region
16q12. Am J Med Genet. 46:61–67. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huxley AF and Niedergerke R: Structural
changes in muscle during contraction: Interference microscopy of
living muscle fibres. Nature. 173:971–973. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huxley H and Hanson J: Changes in the
cross-striations of muscle during contraction and stretch and their
structural interpretation. Nature. 173:973–976. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu L, Vranckx R, Khau Van Kien P, Lalande
A, Boisset N, Mathieu F, Wegman M, Glancy L, Gasc JM, Brunotte F,
et al: Mutations in myosin heavy chain 11 cause a syndrome
associating thoracic aortic aneurysm/aortic dissection and patent
ductus arteriosus. Nat Genet. 38:343–349. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pannu H, Tran-Fadulu V, Papke CL, Scherer
S, Liu Y, Presley C, Guo D, Estrera AL, Safi HJ, Brasier AR, et al:
MYH11 mutations result in a distinct vascular pathology driven by
insulin-like growth factor 1 and angiotensin II. Hum Mol Genet.
16:2453–2462. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xi WD, Liu YJ, Sun XB, Shan J, Yi L and
Zhang TT: Bioinformatics analysis of RNA-seq data revealed critical
genes in colon adenocarcinoma. Eur Rev Med Pharmacol Sci.
21:3012–3020. 2017.PubMed/NCBI
|
|
9
|
Wang RJ, Wu P, Cai GX, Wang ZM, Xu Y, Peng
JJ, Sheng WQ, Lu HF and Cai SJ: Down-regulated MYH11 expression
correlates with poor prognosis in stage II and III colorectal
cancer. Asian Pac J Cancer Prev. 15:7223–7228. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu J, Zhou L, Song Z, Xiong M, Zhang Y,
Yang Y, Chen K and Chen Z: The identification of new biomarkers for
bladder cancer: A study based on TCGA and GEO datasets. J Cell
Physiol. Feb 18–2019.(Epub ahead of print). View Article : Google Scholar
|
|
11
|
Su J, Zhang Y, Su H, Zhang C and Li W: A
recurrence model for laryngeal cancer based on SVM and gene
function clustering. Acta Otolaryngol. 137:557–562. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Islam T, Rahman R, Gov E, Turanli B,
Gulfidan G, Haque A, Arga KY and Haque Mollah N: Drug targeting and
biomarkers in head and neck cancers: Insights from systems biology
analyses. OMICS. 22:422–436. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Krendel M and Mooseker MS: Myosins: Tails
(and Heads) of functional diversity. Physiology (Bethesda).
20:239–251. 2005.PubMed/NCBI
|
|
14
|
Pollard TD and Weihing RR: Actin and
myosin and cell movemen. CRC Crit Rev Biochem. 2:1–65. 2008.
View Article : Google Scholar
|
|
15
|
Ma Q, Xu Y, Liao H, Cai Y, Xu L, Xiao D,
Liu C, Pu W, Zhong X and Guo X: Identification and validation of
key genes associated with non-small-cell lung cancer. J Cell
Physiol. 234:22742–22752. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Findeisen P, Röckel M, Nees M, Röder C,
Kienle P, Von Knebel Doeberitz M, Kalthoff H and Neumaier M:
Systematic identification and validation of candidate genes for
detection of circulating tumor cells in peripheral blood specimens
of colorectal cancer patients. Int J Oncol. 33:1001–1010.
2008.PubMed/NCBI
|
|
17
|
Rhodes DR, Kalyana-Sundaram S, Mahavisno
V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ,
Kincead-Beal C, et al: Oncomine 3. 0: Genes, pathways, and networks
in a collection of 18, 000 cancer gene expression profiles.
Neoplasia. 9:166–180. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagy A, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang S, Kim CY, Hwang S, Kim E, Kim H,
Shim H and Lee I: COEXPEDIA: Exploring biomedical hypotheses via
co-expressions associated with medical subject headings (MeSH).
Nucleic Acids Res. 45:D389–D936. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bhattacharjee A, Richards WG, Staunton J,
Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et
al: Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adenocarcinoma subclasses. Proc Natl
Acad Sci USA. 98:13790–13795. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al:
Gene-expression profiles predict survival of patients with lung
adenocarcinoma. Nat Med. 8:816–824. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stearman RS, Dwyer-Nield L, Zerbe L,
Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT,
Franklin WA, et al: Analysis of orthologous gene expression between
human pulmonary adenocarcinoma and a carcinogen-induced murine
model. Am J Pathol. 167:1763–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Talbot SG, Estilo C, Maghami E, Sarkaria
IS, Pham DK, O-charoenrat P, Socci ND, Ngai I, Carlson D, Ghossein
R, et al: Gene expression profiling allows distinction between
primary and metastatic squamous cell carcinomas in the lung. Cancer
Res. 65:3063–3071. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hou J, Aerts J, den Hamer B, van Ijcken W,
den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens
JA, Hoogsteden HC, et al: Gene expression-based classification of
non-small cell lung carcinomas and survival prediction. PLoS One.
5:e103122010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su LJ, Chang CW, Wu YC, Chen KC, Lin CJ,
Liang SC, Lin CH, Whang-Peng J, Hsu SL, Chen CH and Huang CY:
Selection of DDX5 as a novel internal control for Q-RT- PCR from
microarray data using a block bootstrap re-sampling scheme. BMC
Genomics. 8:1402007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Selamat SA, Chung BS, Girard L, Zhang W,
Zhang Y, Campan M, Siegmund KD, Koss MN, Hagen JA, Lam WL, et al:
Genome-scale analysis of DNA methylation in lung adenocarcinoma and
integration with mRNA expression. Genome Res. 22:1197–1211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Alhopuro P, Karhu A, Winqvist R, Waltering
K, Visakorpi T and Aaltonen LA: Somatic mutation analysis of MYH11
in breast and prostate cancer. BMC Cancer. 8:2632008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng Z, Liu P, Marlton P, Claxton DF, Lane
S, Callen DF, Collins FS and Siciliano MJ: Smooth muscle myosin
heavy chain locus (MYH11) maps to 16p13.13-p13.12 and establishes a
new region of conserved synteny between human 16p and mouse 16.
Genomics. 18:156–159. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Trybus KM: Regulation of smooth muscle
myosin. Cell Motil Cytoskeleton. 18:81–85. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Issouf M, Vargas A, Boivin R and Lavoie
JP: SRSF6 is upregulated in asthmatic horses and involved in the
MYH11 SMB expression. Physiol Rep. 6:e138962018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goyama S and Mulloy JC: Molecular
pathogenesis of core binding factor leukemia: Current knowledge and
future prospects. Int J Hematol. 94:126–133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu P, Tarlé SA, Hajra A, Claxton DF,
Marlton P, Freedman M, Siciliano MJ and Collins FS: Fusion between
transcription factor CBF beta/PEBP2 beta and a myosin heavy chain
in acute myeloid leukemia. Science. 261:1041–1044. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ning X and Deng Y: Identification of key
pathways and genes influencing prognosis in bladder urothelial
carcinoma. Onco Targets Ther. 10:1673–1686. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Seitz S, Korsching E, Weimer J, Jacobsen
A, Arnold N, Meindl A, Arnold W, Gustavus D, Klebig C, Petersen I
and Scherneck S: Genetic background of different cancer cell lines
influences the gene set involved in chromosome 8 mediated breast
tumor suppression. Genes Chromosomes Cancer. 45:612–627. 2010.
View Article : Google Scholar
|
|
39
|
Alhopuro P, Phichith D, Tuupanen S,
Sammalkorpi H, Nybondas M, Saharinen J, Robinson JP, Yang Z, Chen
LQ, Orntoft T, et al: Unregulated smooth-muscle myosin in human
intestinal neoplasia. Proc Natl Acad Sci USA. 105:5513–5518. 2008.
View Article : Google Scholar : PubMed/NCBI
|
